Abstract
Introduction/BackgroundTwo randomized controlled trials on the role of secondary cytoreductive surgery in platinum-sensitive Recurrent Ovarian Cancer (ROC) patients have shown contrasting results in terms of PFS and OS. Even more...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
